CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-17 | Carey John F VP of Operations | Sale | −449 | $63.70 | $29K | 14,234 |
| 2023-01-17 | Carey John F VP of Operations | Sale | −114 | $64.30 | $7K | 14,120 |
| 2023-01-17 | Carey John F VP of Operations | Exercise or conversion · Stock Option (Right to Buy) | −1,410 | 13,590 | ||
| 2023-01-13 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion | +5,900 | $16.00 | $94K | 7,200 |
| 2023-01-13 | Khayal Tamer I Chief Commercial Officer | Sale | −5,900 | $60.20 | $355K | 1,300 |
| 2023-01-13 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,900 | 54,285 | ||
| 2023-01-03 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion | +4,100 | $16.00 | $66K | 5,400 |
| 2023-01-03 | Khayal Tamer I Chief Commercial Officer | Sale | −900 | $60.93 | $55K | 4,500 |
| 2023-01-03 | Khayal Tamer I Chief Commercial Officer | Sale | −2,700 | $61.99 | $167K | 1,800 |
| 2023-01-03 | Khayal Tamer I Chief Commercial Officer | Sale | −500 | $62.79 | $31K | 1,300 |
| 2023-01-03 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) | −4,100 | 60,185 | ||
| 2022-12-15 | DAMME LAURA VP, Clinical Affairs | Exercise or conversion | +250 | $38.46 | $10K | 250 |
| 2022-12-15 | DAMME LAURA VP, Clinical Affairs | Sale | −250 | $60.02 | $15K | 0 |
| 2022-12-15 | DAMME LAURA VP, Clinical Affairs | Exercise or conversion | +4,740 | $38.46 | $182K | 4,740 |
| 2022-12-15 | DAMME LAURA VP, Clinical Affairs | Sale | −4,740 | $58.96 | $279K | 0 |
| 2022-12-15 | DAMME LAURA VP, Clinical Affairs | Exercise or conversion · Stock Option (Right to Buy) | −250 | 18,803 | ||
| 2022-12-15 | DAMME LAURA VP, Clinical Affairs | Exercise or conversion · Stock Option (Right to Buy) | −4,740 | 14,063 | ||
| 2022-12-14 | DAMME LAURA VP, Clinical Affairs | Exercise or conversion | +5,947 | $38.46 | $229K | 5,947 |
| 2022-12-14 | DAMME LAURA VP, Clinical Affairs | Sale | −5,947 | $62.43 | $371K | 0 |
| 2022-12-14 | DAMME LAURA VP, Clinical Affairs | Exercise or conversion · Stock Option (Right to Buy) | −5,947 | 19,053 |
Page 31 of 38 · 744 trades